20.400
+9,09%
2026-10-19
Fundamental Analysis
63 / 100—Rubric: Manufacturing
Not rated — insufficient or unsupported data
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +69187.2% | +23242.4% | 2 / 3 | — | — | — | +28.6% | 0.00 | 8.94 | 0,0 | — | — | — | 8.94 | 32.84 | −72,8% |
| Pts | 12 | 12 | 8 | 0 | 0 | 0 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 20.400 (close price on 2026-10-19)EPS (TTM): 2.282
Financial charts
1.Revenue & growth
VND bn-114Q2/26
1.Revenue & growth
VND bn-114Q2/26
2.Profit & growth
VND bn3,14Q2/26
3.Profit mix (Penman)
VND bn7,11Q2/26
4.Margins & cost structure
%1.4%Q2/26
5.Returns & cash cycle
% · days4.1%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn37,1Q2/26
8.Funding & debt health
VND bn · times37,1Q2/26
9.Revenue backlog
VND bn1,27Q2/26
10.Valuation
times · %11,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %873Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
270%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
80.0%
Source: vnstockData through Q2/26